Comparison 3. Alpha‐blocker and usual care versus usual care: stone location subgroup (renal versus ureter; post hoc).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
3.1 Stone clearance	24	2646	Risk Ratio (M‐H, Random, 95% CI)	1.21 [1.11, 1.33]
3.1.1 Renal	12	1483	Risk Ratio (M‐H, Random, 95% CI)	1.13 [1.03, 1.24]
3.1.2 Ureter	13	1163	Risk Ratio (M‐H, Random, 95% CI)	1.31 [1.14, 1.51]
3.2 Auxiliary treatment	12	1251	Risk Ratio (M‐H, Random, 95% CI)	0.67 [0.45, 1.00]
3.2.1 Renal	8	922	Risk Ratio (M‐H, Random, 95% CI)	0.52 [0.25, 1.08]
3.2.2 Ureteral	4	329	Risk Ratio (M‐H, Random, 95% CI)	0.74 [0.44, 1.25]
3.3 Major adverse events	7	747	Risk Ratio (M‐H, Random, 95% CI)	0.60 [0.46, 0.80]
3.3.1 Renal	6	617	Risk Ratio (M‐H, Random, 95% CI)	0.59 [0.44, 0.79]
3.3.2 Ureteral	1	130	Risk Ratio (M‐H, Random, 95% CI)	1.00 [0.26, 3.83]